Related references
Note: Only part of the references are listed.Citalopram Treatment in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior
Fred R. Volkmar
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior Citalopram Ineffective in Children With Autism
Bryan H. King et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
A synaptic trek to autism
Thomas Bourgeron
CURRENT OPINION IN NEUROBIOLOGY (2009)
Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability
Mu Yang et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
E. Berry-Kravis et al.
JOURNAL OF MEDICAL GENETICS (2009)
Pharmacological Inhibition of mTORC1 Suppresses Anatomical, Cellular, and Behavioral Abnormalities in Neural-Specific Pten Knock-Out Mice
Jing Zhou et al.
JOURNAL OF NEUROSCIENCE (2009)
The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine
Michael C. Montana et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Risperidone alters food intake, core body temperature, and locomotor activity in mice
Mark B. Cope et al.
PHYSIOLOGY & BEHAVIOR (2009)
Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice
Danielle A. Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
C. Lintas et al.
JOURNAL OF MEDICAL GENETICS (2009)
Anxiety in children and adolescents with autism spectrum disorders
Susan W. White et al.
CLINICAL PSYCHOLOGY REVIEW (2009)
Minimal Aberrant Behavioral Phenotypes of Neuroligin-3 R451C Knockin Mice
Kathryn K. Chadman et al.
AUTISM RESEARCH (2008)
Reversal of Sensorimotor Gating Abnormalities in Fmr1 Knockout Mice Carrying a Human FMR1 Transgene
Richard Paylor et al.
BEHAVIORAL NEUROSCIENCE (2008)
Social behavior in Fmr1 knockout mice carrying a human FMR1 transgene
Corinne A. Spencer et al.
BEHAVIORAL NEUROSCIENCE (2008)
Social approach and repetitive behavior in eleven inbred mouse strains
Sheryl S. Moy et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice
Liesbeth A. Bruins Slot et al.
BEHAVIOURAL PHARMACOLOGY (2008)
Autism-like behavioral phenotypes in BTBR T+tf/J mice
H. G. McFarlane et al.
GENES BRAIN AND BEHAVIOR (2008)
Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice
Denis G. M. Jugloff et al.
HUMAN MOLECULAR GENETICS (2008)
Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability
Mihir S. Parikh et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2008)
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function
Lynsey Meikle et al.
JOURNAL OF NEUROSCIENCE (2008)
Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome
Gul Dolen et al.
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
Dan Ehninger et al.
NATURE MEDICINE (2008)
Advances in autism genetics: on the threshold of a new neurobiology
Brett S. Abrahams et al.
NATURE REVIEWS GENETICS (2008)
Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice
Fernke M. S. de Vrij et al.
NEUROBIOLOGY OF DISEASE (2008)
Reversing Neurodevelopmental Disorders in Adults
Dan Ehninger et al.
NEURON (2008)
The 'Fractionable Autism Triad': A Review of Evidence from Behavioural, Genetic, Cognitive and Neural Research
Francesca Happe et al.
NEUROPSYCHOLOGY REVIEW (2008)
Unusual Repertoire of Vocalizations in the BTBR T plus tf/J Mouse Model of Autism
Maria Luisa Scattoni et al.
PLOS ONE (2008)
Role of GSK3β in behavioral abnormalities induced by serotonin deficiency
Jean-Martin Beaulieu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Diagnosis of autism spectrum disorders in the first 3 years of life
Rebecca J. Landa
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Social skills interventions for children with Asperger's syndrome or high-functioning autism: A review and recommendations
Patricia A. Rao et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2008)
Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders
Latha Soorya et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2008)
Developing drugs for core social and communication impairment in autism
David J. Posey et al.
CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA (2008)
Fragile X: Translation in action
Mark F. Bear et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: Role of mGluR1/5 and mTOR
Theodore J. Price et al.
JOURNAL OF NEUROSCIENCE (2007)
Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers
Mu Yang et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2007)
Social skills development in children with autism spectrum disorders: A review of the intervention research
Susan Williams White et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2007)
Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome
Michael Ogier et al.
JOURNAL OF NEUROSCIENCE (2007)
Mouse behavioral assays relevant to the symptoms of autism
Jacqueline N. Crawley
BRAIN PATHOLOGY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Jeffrey M. Welch et al.
NATURE (2007)
Stress-induced hyperthermia: Effects of acute and repeated dosing of MPEP
Rebecca E. Nordquist et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice
Mansuo L. Hayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders
Linda M. Rorick-Kehn et al.
PSYCHOPHARMACOLOGY (2007)
Reversal of neurological defects in a mouse model of Rett syndrome
Jacky Guy et al.
SCIENCE (2007)
Early pharmacological treatment of autism: A rationale for developmental treatment
Terrence C. Bethea et al.
BIOLOGICAL PSYCHIATRY (2007)
Assessing autism-like behavior in mice: Variations in social interactions among inbred strains
Valerie J. Bolivar et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Modeling early cortical serotonergic deficits in autism
Carolyn B. Boylan et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
BALB/c mice: Low sociability and other phenotypes that may be relevant to autism
Edward S. Brodkin
BEHAVIOURAL BRAIN RESEARCH (2007)
Animal models of restricted repetitive behavior in autism
Mark H. Lewis et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains
Sheryl S. Moy et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Galanin receptor subtype 2 (GalR2) null mutant mice display an anxiogenic-like phenotype specific to the elevated plus-maze
Kathleen R. Bailey et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2007)
Restricted and repetitive behaviors in young children with autism spectrum disorders
Jennifer Richler et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2007)
Ontogeny of brain and blood serotonin levels in 5-HT1A receptor knockout mice:: potential relevance to the neurobiology of autism
Skirmantas Janusonis et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction
Gary E. Duncan et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: A controlled trial
Elizabeth Berry-Kravis et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2006)
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Antonio M. Persico et al.
TRENDS IN NEUROSCIENCES (2006)
The developmental neurobiology of autism spectrum disorder
Emanuel DiCicco-Bloom et al.
JOURNAL OF NEUROSCIENCE (2006)
Pten regulates neuronal arborization and social interaction in mice
Chang-Hyuk Kwon et al.
NEURON (2006)
Role of risperidone in children with autism spectrum disorder
Benjamin Chavez et al.
ANNALS OF PHARMACOTHERAPY (2006)
Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability
A Kolevzon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
QJ Yan et al.
NEUROPHARMACOLOGY (2005)
Autism spectrum traits in children with mood and anxiety disorders
KE Towbin et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2005)
Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology
CJ McDougle et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles
GB Varty et al.
PSYCHOPHARMACOLOGY (2005)
Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome
SMJ McBride et al.
NEURON (2005)
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism
E Hollander et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?
PM Whitaker-Azmitia
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2005)
Risperidone reduction of amphetamine-induced self-injurious behavior in mice
GC Wagner et al.
NEUROPHARMACOLOGY (2004)
The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine, (MTEP) in rodent models of anxiety
CS Busse et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Automated apparatus for quantitation of social approach behaviors in mice
JJ Nadler et al.
GENES BRAIN AND BEHAVIOR (2004)
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice
SS Moy et al.
GENES BRAIN AND BEHAVIOR (2004)
In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)
JJ Anderson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Antidyskinetic effects of risperidone on animal models of tardive dyskinesia in mice
RC Carvalho et al.
BRAIN RESEARCH BULLETIN (2003)
[3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy:: Potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor
NDP Cosford et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Anxiolytic-like activity of the mGluR5 antagonist MPEP - A comparison with diazepam and buspirone
J Brodkin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
A Pilc et al.
NEUROPHARMACOLOGY (2002)
Risperidone in children with autism and serious behavioral problems
JT McCracken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The social deficits of the oxytocin knockout mouse
JT Winslow et al.
NEUROPEPTIDES (2002)
Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia
GM Anderson et al.
MOLECULAR PSYCHIATRY (2002)
A systematic review of the use of atypical antipsychotics in autism
L Barnard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
The Autism Genetic Resource Exchange: A resource for the study of autism and related neuropsychiatric conditions
DH Geschwind et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist
E Tatarczynska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain
K Walker et al.
NEUROPHARMACOLOGY (2001)
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia
K Walker et al.
NEUROPHARMACOLOGY (2001)
Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism
DM O'Leary et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Effects of the prototypical mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats
WPJM Spooren et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Varieties of repetitive behavior in autism: Comparisons to mental retardation
JW Bodfish et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2000)
The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder
E Hollander et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse
JT Winslow et al.
HORMONES AND BEHAVIOR (2000)
Share Paper
